发明名称 |
TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS |
摘要 |
The invention provides methods of inducing an immune response to cancer comprising co-administering to a cancer patient one or more TLR9 agonists and one or more checkpoint inhibitors. Preferably, the one or more TLR9 agonists are administered to the patient via intratumoral (i.t.) administration. |
申请公布号 |
WO2016057898(A1) |
申请公布日期 |
2016.04.14 |
申请号 |
WO2015US54899 |
申请日期 |
2015.10.09 |
申请人 |
IDERA PHARMACEUTICALS, INC. |
发明人 |
WANG, DAQING;JIANG, WAYNE;AGRAWAL, SUDHIR |
分类号 |
A61K39/39;A61N5/00;C07K14/435 |
主分类号 |
A61K39/39 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|